Short Term Atorvastatin Regime for Vasculopathic Surgical (STAR-VaS) Patients Study.
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2018
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial ischaemia
- Focus Pharmacodynamics
- Acronyms STAR-VaS
- 11 Jun 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 24 Oct 2011 Planned end date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.